Mitochondrial Therapeutics for Neurological Diseases
a solution to mitochondrial dysfunction
Innovative
Patented treatment for several disease indications including epilepsy, Parkinson’s, and rare mitochondrial disorders.
Learn more
Validated
Proprietary VK analogs are orally bioavailable, well tolerated, have excellent brain penetration and half-life.
Learn more
Trusted
Our management and advisory team have achieved countless accolades and recognition in their respective specialties.
Learn more
New Mechanisms of Action
Critical Need for Neurological Diseases Treatments
Neurological diseases are diverse. However, a common trait of many neurological diseases is mitochondrial dysfunction. Neuroene Therapeutics has identified a novel class of compounds based on naturally occurring VK whose central naphthoquinone moiety targets mitochondrial health and energetics. There is a significant unmet need across a wide variety of neurological diseases for such a platform.